Geode Capital Management’s Theravance Biopharma TBPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.86M Buy
893,983
+3,416
+0.4% +$37.7K ﹤0.01% 2375
2025
Q1
$7.95M Buy
890,567
+27,765
+3% +$248K ﹤0.01% 2427
2024
Q4
$8.12M Buy
862,802
+4,823
+0.6% +$45.4K ﹤0.01% 2489
2024
Q3
$6.92M Buy
857,979
+593
+0.1% +$4.78K ﹤0.01% 2576
2024
Q2
$7.27M Sell
857,386
-110,066
-11% -$933K ﹤0.01% 2518
2024
Q1
$8.68M Sell
967,452
-26,548
-3% -$238K ﹤0.01% 2406
2023
Q4
$11.2M Sell
994,000
-67,177
-6% -$755K ﹤0.01% 2279
2023
Q3
$9.16M Sell
1,061,177
-104,485
-9% -$902K ﹤0.01% 2324
2023
Q2
$12.1M Sell
1,165,662
-20,347
-2% -$211K ﹤0.01% 2179
2023
Q1
$12.9M Buy
1,186,009
+45,256
+4% +$491K ﹤0.01% 2096
2022
Q4
$12.8M Buy
1,140,753
+61,666
+6% +$692K ﹤0.01% 2082
2022
Q3
$10.9M Buy
1,079,087
+51,423
+5% +$521K ﹤0.01% 2183
2022
Q2
$9.31M Buy
1,027,664
+17,501
+2% +$159K ﹤0.01% 2302
2022
Q1
$9.66M Sell
1,010,163
-31,669
-3% -$303K ﹤0.01% 2367
2021
Q4
$11.5M Buy
1,041,832
+346,328
+50% +$3.83M ﹤0.01% 2353
2021
Q3
$5.15M Sell
695,504
-236,764
-25% -$1.75M ﹤0.01% 2903
2021
Q2
$13.5M Buy
932,268
+93,905
+11% +$1.36M ﹤0.01% 2248
2021
Q1
$17.1M Buy
838,363
+83,878
+11% +$1.71M ﹤0.01% 1974
2020
Q4
$13.4M Buy
754,485
+16,390
+2% +$291K ﹤0.01% 1961
2020
Q3
$10.9M Buy
738,095
+16,662
+2% +$246K ﹤0.01% 1886
2020
Q2
$15.1M Buy
721,433
+2,361
+0.3% +$49.6K ﹤0.01% 1688
2020
Q1
$16.6M Buy
719,072
+107,724
+18% +$2.49M ﹤0.01% 1424
2019
Q4
$15.8M Sell
611,348
-1,051
-0.2% -$27.2K ﹤0.01% 1713
2019
Q3
$11.9M Buy
612,399
+26,658
+5% +$519K ﹤0.01% 1816
2019
Q2
$9.57M Buy
585,741
+41,712
+8% +$681K ﹤0.01% 1994
2019
Q1
$12.3M Buy
544,029
+46,805
+9% +$1.06M ﹤0.01% 1751
2018
Q4
$12.7M Buy
497,224
+46,003
+10% +$1.18M ﹤0.01% 1613
2018
Q3
$14.7M Buy
451,221
+16,500
+4% +$539K ﹤0.01% 1635
2018
Q2
$9.86M Buy
434,721
+41,712
+11% +$946K ﹤0.01% 1874
2018
Q1
$9.53M Buy
393,009
+19,533
+5% +$474K ﹤0.01% 1802
2017
Q4
$10.4M Buy
373,476
+13,217
+4% +$369K ﹤0.01% 1711
2017
Q3
$12.3M Buy
360,259
+6,709
+2% +$230K ﹤0.01% 1572
2017
Q2
$14.1M Buy
353,550
+23,270
+7% +$927K 0.01% 1448
2017
Q1
$12.2M Buy
330,280
+18,177
+6% +$669K 0.01% 1485
2016
Q4
$9.95M Buy
312,103
+46,103
+17% +$1.47M ﹤0.01% 1578
2016
Q3
$9.64M Buy
266,000
+20,414
+8% +$740K ﹤0.01% 1521
2016
Q2
$5.57M Buy
245,586
+52,347
+27% +$1.19M ﹤0.01% 1841
2016
Q1
$3.63K Buy
193,239
+15,340
+9% +$288 ﹤0.01% 2078
2015
Q4
$2.92M Buy
177,899
+8,698
+5% +$143K ﹤0.01% 2230
2015
Q3
$1.86M Buy
169,201
+7,228
+4% +$79.4K ﹤0.01% 2491
2015
Q2
$2.11M Buy
161,973
+25,069
+18% +$326K ﹤0.01% 2469
2015
Q1
$2.38M Buy
136,904
+1,817
+1% +$31.5K ﹤0.01% 2335
2014
Q4
$2.02M Buy
135,087
+3,327
+3% +$49.6K ﹤0.01% 2428
2014
Q3
$3.04M Buy
131,760
+1,925
+1% +$44.4K ﹤0.01% 2102
2014
Q2
$4.14M Buy
+129,835
New +$4.14M ﹤0.01% 1910